James Gordon
Stock Analyst at JP Morgan
(2.92)
# 1,566
Out of 4,944 analysts
9
Total ratings
83.33%
Success rate
21.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Gordon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Overweight | $775 → $830 | $637.40 | +30.22% | 6 | Aug 4, 2025 | |
| GRFS Grifols | Maintains: Neutral | $7.6 → $10 | $10.60 | -2.83% | 1 | Jun 17, 2025 | |
| GMAB Genmab | Downgrades: Neutral | n/a | $21.87 | - | 1 | Aug 20, 2024 | |
| FGEN FibroGen | Upgrades: Neutral | n/a | $9.25 | - | 1 | Apr 7, 2021 |
argenx SE
Aug 4, 2025
Maintains: Overweight
Price Target: $775 → $830
Current: $637.40
Upside: +30.22%
Grifols
Jun 17, 2025
Maintains: Neutral
Price Target: $7.6 → $10
Current: $10.60
Upside: -2.83%
Genmab
Aug 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $21.87
Upside: -
FibroGen
Apr 7, 2021
Upgrades: Neutral
Price Target: n/a
Current: $9.25
Upside: -